BiosimilarsAlvotech Advances in Biosimilar Market wit...AVT03, a biosimilar candidate for osteoporosis treatment, showed promise in treating bone illnesses, according to results from a pharmacokinetic study by Alvotech SA. more ➔
M&ANovozymes and Chr. Hansen Complete Merger,...Danish Novozymes A/S and Chr. Hansen Holding A/S have completed their merger, creating a new company named Novonesis. more ➔
NGT2:1 for new genomic techniquesFollowing the AGRI Committee of the European Parliament, the lead ENVI Committee has also agreed to relax the rules for the authorisation of NGTs. more ➔
M&AInnate immunity merger raises €75mForbion has spearheaded a €75m Series A financing in Norwegian biotech Calluna Pharma. The clinical-stage company resulted from the merger of Oxitope Pharma and Arxx Therapeutics. more ➔
partnershipRoche jumps ship on AC ImmuneGenentech, Roche’s US subsidiary, is ending its decades-long collaboration with AC Immune SA after disappointing study results. It has handed the global rights to Crenezumab and Semorinemab back to the … more ➔
NGTDeregulation of new genomic techniques bef...After the EU Parliament’s Agriculture (AGRI) Committee called for a patent ban on NGT-1 breeds on 8 January, the ENVI Committee will give its input to the EU Commissions draft law on new genomic tec … more ➔
bioeconomyAmsilk partners with 21st.BIOAMSilk GmbH and Danish 21st.BIO A/S announce partnership to accelerate the production of advanced materials made from spider silk-based proteins. more ➔
financingOnera Health raises US$32m in Series C rou... Sleep diagnostics specialist Onera Health NV has closed a €30m (US$32m) Series C financing round co-led by EQT Life Sciences and Gimv. more ➔
DealSpexis sells antibiotics programme to Basi...Macrocycle library secialist Spexis AG is set to sell a preclinical antibiotics programme afor CHF2m to Basilea Pharmaceutica Ltd. more ➔
financingFinnish Enifer Oy secures €12m grant to...Microbial production specialist Enifer has secured a €12m grant from Business Finland to build a mycoprotein ingredient factory with a capacity of 300,000 tonnes annually. more ➔
